The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 349:187-188 July 10, 2003 Number 2
NextNext

Coronavirus Genomic-Sequence Variations and the Epidemiology of the Severe Acute Respiratory Syndrome

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Tsang, K. W.
-Related Article
 by Lee, N.
-PubMed Citation
To the Editor: Our teaching hospital was the site of a major outbreak of the severe acute respiratory syndrome (SARS).1 We sequenced viral isolates cultured from clinical specimens from seven patients with SARS in this outbreak. The viral isolates were from passage 1 of the SARS coronavirus cultured in Vero cells.2 We obtained the complete genomic sequence of the virus cultured from the mother of the index patient in this hospital outbreak (isolate Su-10, GenBank accession number AY282752).1 The mother's symptoms had begun on March 5, 2003; she died on April 13, 2003. We also sequenced the spike glycoprotein gene from viral isolates cultured from six contacts of the index patient, and all these sequences were identical to that of isolate Su-10.

To investigate whether there were other strains of the SARS coronavirus in Hong Kong at the time of this outbreak, we sequenced the spike glycoprotein gene from isolates of passage 1 virus cultured from four other patients with SARS who had had no contact with the index patient. Sequence variations were observed at two nucleotides (positions 21721 and 22222) (Figure 1) in one isolate (isolate CUHK-W1) and at one nucleotide in two other isolates. Since culturing would be expected to introduce mutations, we compared these sequences with other SARS coronavirus sequences in GenBank. The two nucleotide changes observed in the spike glycoprotein gene of CUHK-W1 could also be observed in several other isolates (GenBank accession numbers AY278489, AY278488, and AY278487), so these were unlikely to be culture-derived artifacts. CUHK-W1 was cultured from a patient who had traveled to Shenzhen, Guangdong Province, China, six days before the onset of his symptoms on March 15, 2003. We therefore sequenced this isolate completely (GenBank accession number AY278554). Of the 10 observed nucleotide differences between Su-10 and CUHK-W1, 7 were also observed in at least one other isolate in GenBank (Figure 1).


View larger version (9K):
[in this window]
[in a new window]
 
Figure 1. Comparison of the Sequences of Two Strains of SARS Coronavirus Isolated from Patients in Hong Kong at the Beginning of the Epidemic.

This schematic representation of the genomic organization of the severe acute respiratory syndrome (SARS) coronavirus shows only selected open reading frames (orf), including orf 1ab (including the polymerase), S (spike glycoprotein), E (envelope protein), M (membrane protein), and N (nucleocapsid protein). Sequence variations at seven positions between the two viral strains (Su-10 and CUHK-W1) are indicated. The nucleotide positions are numbered according to the sequence published by the Centers for Disease Control and Prevention (CDC-Urbani isolate; GenBank accession number AY278741).3

 
Our data show that since the first reports of SARS in November 2002 in Guangdong Province,4 at least two strains of SARS coronavirus have emerged. It is epidemiologically significant that even by mid-March 2003, these two strains of the SARS coronavirus had already been found in patients in Hong Kong. This observation means that there was more than one source of infection present at the beginning of the SARS epidemic in Hong Kong. Therefore, even if there had been no outbreak at the Metropole Hotel,5 SARS would probably have broken out eventually in Hong Kong. These results emphasize the need for vigilance in order to prevent the resurgence of this disease. The results also show the usefulness of spike glycoprotein sequences as a molecular epidemiologic tool.


Stephen K.W. Tsui, Ph.D.
Stephen S.C. Chim, Ph.D.
Y.M. Dennis Lo, D.M.
Chinese University of Hong Kong
Shatin, New Territories, Hong Kong
loym{at}cuhk.edu.hk


for the Chinese University of Hong Kong (CUHK) Molecular SARS Research Group

References

  1. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986-1994. [Free Full Text]
  2. Peiris JS, Lai ST, Poon L, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319-1325. [CrossRef][ISI][Medline]
  3. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-1399. [Free Full Text]
  4. Update: outbreak of severe acute respiratory syndrome -- worldwide, 2003. MMWR Morb Mortal Wkly Rep 2003;52:241-6, 248. [Medline]
  5. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1977-1985. [Free Full Text]

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Tsang, K. W.
-Related Article
 by Lee, N.
-PubMed Citation

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.